Synergy Pharmaceuticals is headquartered in New York, New York.
Synergy Pharmaceuticals has 291 employees.
Synergy Pharmaceuticals is a life science company.
420 Lexington Avenue, Suite 2012,
New York, New York
10170
United States,
(212) 297-0020
www.synergypharma.com
Synergy Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of novel GI therapies. The company has pioneered discovery, research and development efforts on analogs of uroguanylin, a naturally occurring and endogenous human GI peptide, for the treatment of GI diseases and disorders. Synergy’s proprietary GI platform includes one commercial product TRULANCE and a second lead product candidate, dolcanatide.
| Year | ≤ '20 | '21 | '22 | '23 | '24 | '25 | T | |
|---|---|---|---|---|---|---|---|---|
| Buy (0.0/yr) | # | - | - | - | - | - | - | 0 |
| Sell (0.0/yr) | # | 1 | - | - | - | - | - | 1 |
| vol | $195M | $195M | ||||||
| 1 | ||||||||
| Financial | Deals |
|---|---|
|
Centerview Partners |
1 |
| Legal | Deals |
|---|---|
|
Sheppard Mullin Richter & Hampton |
1 |
|
Skadden, Arps, Slate, Meagher & Flom |
1 |
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
